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Dear Editor,
Brenner tumor is a rare ovarian tumor that may be benign,
borderline, or malignant. Malignant Brenner tumor (MBT)
accounts for only 2e5% of all Brenner tumors and is
extremely rare in individuals over the age of 65 years [1].
Case 1. A 68-year-old female patient presented with
abdominal distension. The patient had been post-
menopausal for 27 years. Physical examination showed a
left adnexal mass. Transvaginal ultrasonography showed an
endometrial thickness of 6.5 mm and a solid mass with a
diameter of 10 cm at the left adnexal region. CA-125 value
was 103.5 U/mL. Total abdominal hysterectomy, bilateral
salpingo-oophorectomy, pelvic and paraaortic lymph node
dissection, and omentectomy were performed. The result
of histopathological examination was a malignant Brenner
tumor (Fig. 1A), simple endometrial hyperplasia, and
endometrial polyp. There was omental metastasis. Immu-
nohistochemistry staining results were positive for: WT-1,
cytokeratin 7, calretinin, CA-125, Estrogen receptor (ER)
80%, Ki-67 60%, and p53 100% and negative for BerEp4,
cytokeratin20, uroplakin, Progesterone receptor (PR), and
p63. Chemotherapy was planned at the tumor board.
Case 2. A 76-year-old female patient presented with
abdominal pain. The patient had been postmenopausal
for 15 years. Computerized tomography scan showed an
irregular mass with a size of 66 mm  45 mm in the right
adnexial region. Total abdominal hysterectomy, bilateral
salpingo-oophorectomy, omentectomy, and lymph node
dissection were performed via laparotomy. Histopatho-
logical examination revealed a malignant Brenner tumor.
Immunohistochemistry staining results were positive for
p63, cytokeratin HMW, Epithelial membrane antigen
(EMA), and Ki-67 30% and negative for ER, PR, p53,
cytokeratin 20, and WT-1. The lymphovascular invasions
with CD31 and CD34 were found. Malignant Brenner tumor
invasion was found in the uterus wall (Fig. 1B). Chemo-
therapy was planned at the tumor board.Conflict of Statement: The authors have no conflicts of interest
relevant to this article.
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http://dx.doi.org/10.1016/j.kjms.2013.01.020The complaints of the patients with MBT are usually a
present abdominal mass or pain. Borah et al. [2] reported a
45-year-old case and Yamamoto et al. [3] reported a 55-
year-old case, whereas Gezginc¸ et al. [4] reported aFigure 1. (A) Cytokeratin 7 immunopositivity in a malignant
Brenner tumor (4). (B) Malignant Brenner tumor invasion into
the uterine wall (10).
ed by Elsevier Taiwan LLC. All rights reserved.
160 Letter to the Editormean age of 55.6 years (the oldest being 79 years) in 13
cases. Brenner tumors have hormonal activity, and most of
these tumors produce estrogen and hence may be associ-
ated with endometrial pathologies. The rate of endometrial
hyperplasia was reported in 4e14% of the cases [5]. Endo-
metrial hyperplasia was found in the first case. Surgical
treatment is essential in the management of MBT as in
other epithelial ovarian malignancies. Our first case pre-
sented with abdominal distention and the second case
presented with abdominal pain. Our patients were 68 years
old and 78 year old, respectively, and the second patient is
one of the oldest patients in the literature. In conclusion,
MBTs are rare and the available information on these tu-
mors is mostly limited to case reports.
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